Interactieve versie
U vindt veel meer informatie per bedrijf en veel meer bedrijven. Ook kunt u filters toepassen en exporteren naar Excel.
Bekijken
AM-Pharma B.V.
Utrecht - Utrecht
www.am-pharma.com
Naam
AM-Pharma B.V.
Website
www.am-pharma.com
Sector
Vervaardiging van farmaceutische producten
Werkenden
10-49 wn.
Adres
Adres verborgen. Dit bedrijf wil geen ongevraagde postreclame of verkoop aan de deur.
Postcode
3521AZ
Plaatsnaam
Utrecht
-147 -5 /10.1093/jbmr/zjaf023 /aacb-19-00031 /asbmr/2025/meetingapp.cgi/paper/5008 /fendo.2023.1138599 /j.1469-1809.2011.00644.x /j.bone.2013.01.024 /j.bone.2014.11.017 /j.bone.2020.115664 /j.metabol.2016.07.006 /j.metabol.2017.08.013 /jbmr.4130 /jbmr/zjaf141 /jbmr/zjaf185 /jci117874 /nrendo.2016.14 /s00198-017-4091-y /s00198-020-05760-y /s13023-022-02420-3 0 1 10 10.1002 10.1007 10.1016 10.1038 10.1093 10.1111 10.1172 10.1186 10.33176 10.3389 1020 11 1138599 115664 11th 12 13 137 14 142 1440 14409383 1445 147 1522 1530 155 161 17 1995 1b 2 20 2011 2013 2014 2015 2016 2017 2018 2020 2021 2022 2023 2025 2026 20th 21 2171 2178 233 246 24th 2505 2513 2653 2662 26th 27 277 27th 28 3 32 35 4 41 41055578 439 445 5 54 5th 65 7 72 75 82 9 95 9su a abl about abstract accept accessed acquired acquires acquisition acros action activity adding additionally addresses administered administration adult adulthod aetiology affected aged agred ahead alfa alkalin all alleviated alpl also am am-pharma ambros american an analysis and and/or animal ann announcement announces annual approach are around as asbmr asbmr.confex.com asbmr.confex.com/asbmr/2025/meetingapp.cgi/paper/5008 asfotas aspect associated avenues b b.v background bas based be becom being ben benefit berkseth bernholz beyond biochem biochemical biological biomarker biomarkersilofotas bl body bon bone-target bones bouy bttr built burd but by c/o cambridg can cartilag cb2 centr characteristic chimeric chondrocalcinosis chronic clear cleav clin clinical collect company complication compound compromised concept condition consequences considerabl constraint contact contain cookies could craniosynostosis cros cross-sectional crystal cs currently d dahir data debilitat dec december demambro demonstrated demonstrates dental dependent develop developed development diagnosed diagnosis dis disability discomfort diseas disease-related disease-specific do does doi doi.org doi.org/10.1093/jbmr/zjaf023 dos dose-dependent drak e effect e
Vind meer informatie over AM-Pharma B.V. in de interactieve versie